DGK-ι Antibodies

Santa Cruz Biotechnology features a diverse variety of DGK-ι monoclonal antibodies for investigating diacylglycerol kinases in cellular signaling. DGK-ι monoclonal antibodies are suitable for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). DGK-ι, or diacylglycerol kinase iota, plays a crucial role in lipid signaling pathways by converting diacylglycerol into phosphatidic acid, thereby regulating various cellular processes such as proliferation, differentiation, and apoptosis. Research has shown DGK-ι involvement in both normal physiology and disease states, including cancer and neurodegenerative disorders. Understanding DGK-ι function can provide insights into potential therapeutic targets and strategies. Scientists worldwide rely on DGK-ι monoclonal antibodies to advance their research in lipid signaling pathways. Exploring DGK-ι's role in cellular processes continues to reveal new possibilities for therapeutic interventions. Santa Cruz Biotechnology monoclonal antibodies for DGK-ι support researchers in making meaningful contributions to scientific understanding of cellular signaling mechanisms.